WHO Consults On New Measures To Improve Medicines Access
Executive Summary
A draft roadmap lists initiatives to be undertaken between 2019 and 2023 to help improve access to medicines and vaccines.
You may also be interested in...
Transparency, IP Issues Dominate Discussion On WHO's Roadmap To Improve Drug Access
Advocacy groups want the WHO's proposed roadmap on improving access to medicines to include stronger language on transparency of R&D costs, prices and revenues. The pharmaceutical industry, however, believes any forward-looking solution should rest upon strong IP protection.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.